ArticleNano-micro letters2026
Dual-Gradient Impedance/Insulation Structured Polyimide Nonwoven Fabric for Multi-Band Compatible Stealth.
Article in Nano-micro letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Self-Oriented Gradient Ionic Skins for Dual-Function Electromagnetic Shielding and Self-Powered Sensing.Nano-micro letters · 2026Article
- Ultra-Broadband Microwave Absorption and Programmable Multispectral Camouflage Enabled by Neural-Network-Driven Impedance-Gradient Metadevices.Nano-micro letters · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Designing and preparing a compatible electromagnetic interference (EMI) shielding, radar and infrared stealth material exhibits significant prospect in the military field. Hence, a novel conductive/magnetic polyimide-based nonwoven fabric (PFN
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.